FDA warns Mex­i­can glyc­erin man­u­fac­tur­er for re­fus­ing an in­spec­tion

A drug man­u­fac­tur­ing fa­cil­i­ty in Mex­i­co is draw­ing the ire of the FDA af­ter it ig­nored the US reg­u­la­tor’s in­spec­tion re­quests and phone calls.

Ac­cord­ing to the warn­ing let­ter is­sued on June 13, Gliceri­nas In­dus­tri­ales re­fused a pre-an­nounced in­spec­tion dur­ing a phone call with FDA pri­or to the in­spec­tion at the com­pa­ny’s fa­cil­i­ty in Za­popan, Mex­i­co, a city next to Guadala­jara, which was planned for May 16 to May 20.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER